Improve access and continuity of care without adding cost, clinical risk, or work for patients.
JA
Joshua ArmahFounder · Pheonix Startups
PUBLIC DESK RESEARCH 14 October 2026 · Edition 01
Full-length, branded PDFs. Enter your email to view or download.
THE MARKET THESIS
Care coordination, affordable access, reliable supplies and administrative workflows deserve as much attention as a new diagnostic model. A useful product must fit the clinical pathway and the organisation that pays for it.
01 / THE EVIDENCE, DRAWN TO SCALE
Make the scale visible.
This is the quantity reported by the cited institution. It is context for a question, rather than a forecast of startup revenue.
SOURCE ESTIMATE
4.6bnSCALE OF THE REPORTED QUANTITY
Each block = 200 million people
people lacking essential health-service access
2023 data; 2025 report Global; coverage estimate
Essential health-service access estimate for 2023, reported in 2025. This is not a count of Pheonix users or a city population estimate.
Visuals reproduce the cited signal, including its original scope. Rounded unit graphics are reading aids; the displayed figure and source definition govern the claim.
THE EVIDENCEGLOBAL CONTEXT, NOT A CITY MARKET SIZE
WHO and the World Bank’s 2025 monitoring report estimates that 4.6 billion people lacked essential health-service access in 2023. Financial hardship estimates refer to 2022; publication year does not make either indicator a 2025 observation.WHO / World Bank
WHO’s health-AI regulatory considerations emphasise safety, effectiveness, data quality and lifecycle oversight. A workflow improvement does not establish that an algorithm is clinically safe or approved for a diagnostic use.World Health Organization
03 / FOLLOW THE SYSTEM
Follow the value. Find the friction.
A proposed operating map for health & care. Read the handoffs before choosing a product to build.
Health system
01
Find & afford care
02
Navigate & schedule
03
Treat safely
04
Coordinate follow-up
05
Reimburse & evaluate
THE BUYER QUESTION
Clinics, hospitals, insurers, public health systems and employers. Confirm the licensed clinical partner, data controller, reimbursement route and budget holder before building a patient-facing intervention.
THE EXPERIMENT
Begin with a bounded non-diagnostic workflow, a clinical owner, consent and appropriate local approvals. Compare completed follow-ups and staff effort with the existing process, and monitor whether difficult-to-reach patients are being excluded.
Read the complete value chain
Find and afford care
Navigate and schedule
Deliver safe treatment
Coordinate follow-up
Reimburse and evaluate
Editorial system map derived from the research brief. The sequence is a framework for discovery, with no claim that a Pheonix programme, customer or pilot is operating.
A PRACTICAL STARTING POINTEDITORIAL FRAMEWORK
How might the business work?
Consider a paid workflow service or contract linked to a verified care process. Analyse implementation costs, clinician time and patient costs together; lower administrative costs do not automatically mean more equitable care.
03 / PROPOSED IMPACT FRAMEWORK
Make the benefit testable.
An impact claim should survive a difficult question. Design the measurement before you design the success story.
01
Establish the baseline
Define the people, geography, existing service and time period. Record the full cost before the intervention.
02
Run a bounded pilot
Use the proposed experiment above as a starting question. Agree the local scope, duration, comparison and safeguards before beginning.
03
Compare the outcome
Ask what would have happened otherwise. Compare like with like and record how much uncertainty remains.
WHAT TO MEASURE
The outcome ledger
Completed referrals
Completed appointments or referrals, not messages sent
Patient cost & time
Patient cost and time to appropriate care
Workload & safety
Clinician workload and safety incidents
Outcomes by access
Outcomes broken down by relevant access barriers
↳
Keep the counter-evidence.
Check who is left out, what the intervention costs and which negative effects would invalidate the claim. Involve the people expected to benefit.
Proposed measurement pathway. No baseline, pilot result, participant count or achieved impact is being reported in this diagram.
WATCH THE TRADEOFF
What could change the case?
Clinical claims require evidence appropriate to the intended use.
Sensitive data creates duties beyond ordinary analytics.
Optimising for easy patients can make an apparent success less equitable.
QUESTIONS BEFORE THE FIRST PILOT
Where does the patient pathway fail today?
Who has authority to change the workflow?
Would the intervention still work without a smartphone?
THE READING LIST2 REFERENCES
Follow the evidence.
Publication dates and geographic scope are shown for each source. Linked institutions are references, with no affiliation or endorsement implied.
Based in Santa Monica, California, Pheonix Startups is launching globally. Founders and investors everywhere are invited to apply. Introduce yourself in 15 seconds, then book your interview.